Akriveia Therapeutics' Series B Round

Akriveia Therapeutics raised a round of funding on January 31, 2018.

Akriveia Therapeutics is pursuing the discovery and development of next generation cancer immunotherapies. Akriveia believes its new agents offer the promise of a more efficacious and safer approach t…

Articles about Akriveia Therapeutics' Series B Round: